A new mesangial triumvirate: sulfonylureas, their receptors and endosulfines.


Although sulfonylureas have long been therapeutically utilized for their hypoglycemic properties in type 2 diabetic patients, there is a paucity of clinical or experimental data that suggests that this pharmacotherapeutic class confers a benefit on the course of diabetic renal disease. Because the mesangial compartment is central to the fibrogenic response… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.